Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.
Park HS, Lee DH, Kang DH, Yeo MK, Bae G, Lee D, Yoo G, Kim JO, Moon E, Huh YH, Lee SH, Jo EK, Cho SY, Lee JE, Chung C.
Park HS, et al.
Cancer Med. 2021 Feb;10(4):1405-1417. doi: 10.1002/cam4.3734. Epub 2021 Jan 23.
Cancer Med. 2021.
PMID: 33486901
Free PMC article.